Position
Squarepoint Ops LLC in Atea Pharmaceuticals, Inc.
Back to the book · All holders of AVIR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $35K$3.57 → $5.38
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 19.3K | $68.9K | — | — | — | 0.0% |
| Q1 2026 | 55.1K | $296.4K | $5.38 | $35K | $192.5K | 0.0% |